The global industry for therapeutics targeting IgG4-related disease is observing substantial expansion. Driven by an rising prevalence of these immunological conditions and the presence of novel treatment solutions, the market is poised for significant potential in the near future. Key factors stimulating this development include a growing recog… Read More